Kewaunee Scientific Co. (NASDAQ:KEQU) is Minerva Advisors LLC’s 10th Largest Position

Minerva Advisors LLC grew its stake in shares of Kewaunee Scientific Co. (NASDAQ:KEQU) by 4.1% in the fourth quarter, HoldingsChannel.com reports. The firm owned 109,493 shares of the technology company’s stock after buying an additional 4,311 shares during the quarter. Kewaunee Scientific comprises approximately 3.9% of Minerva Advisors LLC’s holdings, making the stock its 10th largest holding. Minerva Advisors LLC’s holdings in Kewaunee Scientific were worth $6,668,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently made changes to their positions in the stock. JPMorgan Chase & Co. lifted its stake in Kewaunee Scientific by 18,000.0% in the third quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company’s stock worth $30,000 after acquiring an additional 900 shares during the period. IFP Advisors Inc purchased a new stake in Kewaunee Scientific in the fourth quarter worth $36,000. Barclays PLC purchased a new stake in Kewaunee Scientific in the third quarter worth $121,000. State Street Corp purchased a new stake in Kewaunee Scientific in the third quarter worth $266,000. Finally, Janney Montgomery Scott LLC purchased a new stake in Kewaunee Scientific in the fourth quarter worth $338,000. Hedge funds and other institutional investors own 32.69% of the company’s stock.

Insider Buying and Selling at Kewaunee Scientific

In other Kewaunee Scientific news, CEO Thomas David Hull III sold 2,000 shares of the firm’s stock in a transaction on Thursday, December 26th. The stock was sold at an average price of $63.01, for a total transaction of $126,020.00. Following the completion of the transaction, the chief executive officer now owns 42,497 shares of the company’s stock, valued at approximately $2,677,735.97. This trade represents a 4.49 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, VP Elizabeth D. Phillips sold 1,850 shares of the firm’s stock in a transaction on Tuesday, December 17th. The shares were sold at an average price of $54.17, for a total value of $100,214.50. Following the transaction, the vice president now owns 13,591 shares of the company’s stock, valued at $736,224.47. The trade was a 11.98 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 11,994 shares of company stock valued at $729,430. 14.20% of the stock is currently owned by company insiders.

Kewaunee Scientific Stock Performance

Shares of Kewaunee Scientific stock opened at $54.25 on Tuesday. The company has a current ratio of 2.64, a quick ratio of 2.13 and a debt-to-equity ratio of 0.45. The firm has a market capitalization of $155.70 million, a P/E ratio of 8.60 and a beta of 0.71. The business has a fifty day simple moving average of $61.05 and a two-hundred day simple moving average of $47.73. Kewaunee Scientific Co. has a 12 month low of $27.00 and a 12 month high of $71.33.

Kewaunee Scientific (NASDAQ:KEQU) last announced its quarterly earnings data on Wednesday, December 11th. The technology company reported $1.41 EPS for the quarter. Kewaunee Scientific had a return on equity of 25.83% and a net margin of 9.39%.

Analyst Ratings Changes

Separately, StockNews.com raised Kewaunee Scientific from a “hold” rating to a “buy” rating in a research note on Wednesday, December 18th.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.